BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr | ₹-3.82 Cr | ₹-7.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BLISS GVS PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-1.27 Cr |
Mar2023 | ₹1.62 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹-3.82 Cr |
Mar2020 | ₹-7.50 Cr |
How is Net Cash Inflow / Outflow of BLISS GVS PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-1.27 Cr | Negative | |
Mar2023 | ₹1.62 Cr | -91.35 | |
Mar2022 | ₹19 Cr | Positive | |
Mar2021 | ₹-3.82 Cr | Negative | |
Mar2020 | ₹-7.50 Cr | - |
Compare Net Cash Inflow / Outflow of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,316.4 Cr | 7.3% | 9% | 10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | 7.3% |
9% |
10.2% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses